Home › Funds › Two Seas Capital LP › ROIV

Two Seas Capital LP position in ROIV

ROIVANT SCIENCES LTD · Health Care

Two Seas Capital LP reported holding 2,244,400 shares of ROIV (ROIVANT SCIENCES LTD) in its Q3 2026 13F filing — a position valued at US$82.1M, representing 1.07% of its reported portfolio and ranking #10 among its reported holdings. Two Seas Capital LP has disclosed ROIV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.24M sh
Reported value held$82.08M
Portfolio Weight1.07%
First reportedQ3 2023
Last changeAdd
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How Two Seas Capital LP's ROIV position evolved

Two Seas Capital LP first disclosed a stake in ROIV in Q3 2023 at 7,915,232 shares (US$92.4M). The position peaked in Q4 2024 at 10,167,807 shares, worth US$120.3M. Across 13 filings, Two Seas Capital LP increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 2,244,400 shares valued at US$82.1M — an increase of 761,800 shares quarter over quarter.. Notable position changes include a 77% trim in Q3 2025 (shares rose 43% over the following quarter), a 70% trim in Q1 2026 (shares rose 28% over the following quarter), a 102% increase in Q2 2026 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 7.92M $92.45M New
Q4 2023 8.51M $95.55M Add
Q1 2024 7.93M $83.59M Reduce
Q2 2024 10.32M $109.07M Add
Q3 2024 9.72M $112.23M Reduce
Q4 2024 10.17M $120.29M Add
Q1 2025 10.14M $102.28M Hold
Q2 2025 10.60M $119.44M Add
Q3 2025 2.44M $36.85M Reduce
Q4 2025 2.44M $52.85M Hold
Q1 2026 732.30K $20.28M Reduce
Q2 2026 1.48M $52.47M Add
Q3 2026 2.24M $82.08M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ROIV and 13F data

ROIV (ROIVANT SCIENCES LTD) is a Health Care company. 63 other funds we track also report a position in ROIV — the largest reported positions include QVT Financial LP (US$839.6M), Farallon Capital Management (US$506.4M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$506.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ROIV

All ROIV fund holders →

FAQ

How long has Two Seas Capital LP held ROIV?

Two Seas Capital LP has disclosed ROIV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Two Seas Capital LP's current position in ROIV?

As of Q3 2026, Two Seas Capital LP holds 2.24M shares of ROIV (ROIVANT SCIENCES LTD), valued at $82.08M, representing 1.07% of its reported portfolio and ranking #10.

Has Two Seas Capital LP been buying or selling ROIV?

In the latest 13F filing (Q3 2026), Two Seas Capital LP increased its position in ROIV. The position peaked in Q4 2024 at 10.17M shares.

Which other funds hold ROIV?

Other major institutional holders of ROIV include QVT Financial LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 63 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.